menu
    • menu

    Company profile for Receptor Life Sciences

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Receptor Life Sciences is a pharmaceutical company that applies FDA-approved drug-delivery technologies to develop innovative therapies to address central nervous system disorders that have few safe and effective treatments. Receptor Life Sciences uses these technologies to produce inhaled and oral cannabinoid products that hold the potential to provide precision, consistency, reliability, and convenience. Receptor's delivery ...
    Receptor Life Sciences is a pharmaceutical company that applies FDA-approved drug-delivery technologies to develop innovative therapies to address central nervous system disorders that have few safe and effective treatments. Receptor Life Sciences uses these technologies to produce inhaled and oral cannabinoid products that hold the potential to provide precision, consistency, reliability, and convenience. Receptor's delivery technologies, used in both inhaled and oral FDA-approved prescription drug products, are a validated solution for the three main challenges of cannabinoid medicine: low absorption, poor bioavailability.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Receptor Life SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1200 Fifth Avenue, Suite 1400 Seattle, Washington 98101
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.receptorlife.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Receptor Life Sciences Opens Second (IND) Application with FDA for RLS103
    Receptor Life Sciences Opens Second (IND) Application with FDA for RLS103

    01 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221101005095/en

    BUSINESSWIRE
    01 Nov 2022
    Share Share
    Receptor Life Sciences Begins Dosing with RLS103 in PIb/IIa Study in Anxiety
    Receptor Life Sciences Begins Dosing with RLS103 in PIb/IIa Study in Anxiety

    29 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220629005082/en

    BUSINESSWIRE
    29 Jun 2022
    Share Share
    Receptor Life Sciences Secures $9.7M Financing to Advance RLS103 into Trials
    Receptor Life Sciences Secures $9.7M Financing to Advance RLS103 into Trials

    07 Apr 2022

    // PRESS FELEASE

    https://www.pharmacompass.com/pdf/news/receptor-life-sciences-secures-97m-financing-to-advance-rls103-into-trials-1650091395.pdf

    PRESS FELEASE
    07 Apr 2022
    Share Share
    Receptor Life Sciences Announces FDA Acceptance of IND Application for RLS103
    Receptor Life Sciences Announces FDA Acceptance of IND Application for RLS103

    30 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220330005056/en

    BUSINESSWIRE
    30 Mar 2022
    Share Share
    Receptor Life Sciences publishes its Clinical Pharmacokinetics Study of RLS103.
    Receptor Life Sciences publishes its Clinical Pharmacokinetics Study of RLS103.

    17 Aug 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210817005189/en

    BUSINESSWIRE
    17 Aug 2021
    Share Share
    Receptor Announces Initiation of IND-Opening Clinical PK Study of RLS102
    Receptor Announces Initiation of IND-Opening Clinical PK Study of RLS102

    19 Jul 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210719005086/en

    BUSINESSWIRE
    19 Jul 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search